Alexion Pharmaceuticals News Timeline

Alexion Pharmaceuticals Inc -- USA Stock  

USD 143.16  2.32  1.65%

This is yet another view into Alexion Pharmaceuticals filtered headlines to help investors concentrate on Alexion Pharmaceuticals Inc noise-free news that matters. Some academic researchers believe in strong correlation between financial news and their impacts to the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Alexion Pharmaceuticals headlines in addition to utilizing other more conventional financial analysis modules. Check also Alexion Pharmaceuticals Backtesting and Alexion Pharmaceuticals Hype Analysis
seekingalpha News
October 11, 2017
Your Daily Pharma Scoop Alexion Catalysts, Amgen Prolia, Ultragenyx Borosumab at seekingalpha.com 
View Story
wsj  News
October 17, 2017
How Does Quintiles IMS Holdings, Inc. Stack Up Right Now at www.stocknewsjournal.com 
View Story
news
September 26, 2017
How Do The Margins Look For Quintiles IMS Holdings, Inc. at jctynews.com 
View Story
Macroaxis News
October 17, 2017
Exercise or conversion by Joshua Boger of 1400 shares of Vertex Pharmaceuticals subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
October 17, 2017
44.55 percent to Target, BMO Capital Keeps Hold Rating on Endo International ... at bzweekly.com 
View Story
Macroaxis News
October 17, 2017
Acquisition by Glenn Tilton of 555 shares of Abbott Laboratories subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
October 17, 2017
Allergan plc Ordinary Shares Reaches 202.26 After 9.00 percent Up Move ... at normanobserver.com 
View Story
Macroaxis News
October 17, 2017
Exercise or conversion by Stark James R of 200 shares of Bio Rad subject to Rule 16b-3 at MacroaxisInsider 
View Story
news
September 25, 2017
Risk Malaise Alert in Option Market Bio-Rad Laboratories Inc Implied Price ... at news.cmlviz.com 
View Story